-
- Mark Y. Chan
- From Duke Clinical Research Institute (M.Y.C., R.C.B.), Durham, NC; National University Hospital (M.Y.C.), Singapore, Singapore; Institute of Cardiology (F.A.), Catholic University, Rome, Italy; and Divisions of Cardiology and Hematology (R.C.B.), Duke University School of Medicine, Durham, NC.
-
- Felicita Andreotti
- From Duke Clinical Research Institute (M.Y.C., R.C.B.), Durham, NC; National University Hospital (M.Y.C.), Singapore, Singapore; Institute of Cardiology (F.A.), Catholic University, Rome, Italy; and Divisions of Cardiology and Hematology (R.C.B.), Duke University School of Medicine, Durham, NC.
-
- Richard C. Becker
- From Duke Clinical Research Institute (M.Y.C., R.C.B.), Durham, NC; National University Hospital (M.Y.C.), Singapore, Singapore; Institute of Cardiology (F.A.), Catholic University, Rome, Italy; and Divisions of Cardiology and Hematology (R.C.B.), Duke University School of Medicine, Durham, NC.
収録刊行物
-
- Circulation
-
Circulation 118 (22), 2286-2297, 2008-11-25
Ovid Technologies (Wolters Kluwer Health)
